CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $82.41M, lower than 95% of all stocks globally
- PositionOperating margin is -140.2%, lower than 95% of its Medical Devices peers (median 8.1%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
117.45BKRW82.41M · vs all stocks (USD)
Revenue (TTM)
6.99BKRW4.90M · vs all stocks (USD)
Profit Margin
-102.23%vs Medical Devices peers
52-Week Change
-29.91%vs all stocks
Market Capitalization
117.45BKRW82.41M · vs all stocks (USD)
Enterprise Value
174.12BKRW122.18M · vs all stocks (USD)
Forward P/E
35.86xvs Medical Devices peers
Price to Sales (TTM)
27.63xvs Medical Devices peers
Price to Book (MRQ)
4.39xvs Medical Devices peers
Enterprise to Revenue
24.92xvs Medical Devices peers
Enterprise to EBITDA
-27.57xvs Medical Devices peers
Gross Margin
32.89%vs Medical Devices peers
Profit Margin
-102.23%vs Medical Devices peers
Operating Margin
-140.17%vs Medical Devices peers
Return on Assets (TTM)
-18.99%vs Medical Devices peers
Return on Equity (TTM)
-41.28%vs Medical Devices peers
Revenue (TTM)
6.99BKRW4.90M · vs all stocks (USD)
Revenue per Share (TTM)
938.08KRWUpdated Jul 15, 2026Quarterly Revenue Growth
-21.60%vs Medical Devices peers
Gross Profit (TTM)
3.03BKRW2.13M · vs all stocks (USD)
EBITDA (TTM)
-6.32BKRW-4.43M · vs all stocks (USD)
Net Income (TTM)
-7.14BKRW-5.01M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-28.75%vs Medical Devices peers
Operating Cash Flow (TTM)
-7.09BKRW-4.97M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-7.74BKRW-5.43M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Revenue
7.30BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
3.82BKRWFY2025 · Dec 31, 2025Gross Profit
3.49BKRWFY2025 · Dec 31, 2025Operating Income
-7.53BKRW-5.28M · vs all stocks (USD)
Pre-tax Income
-7.86BKRWFY2025 · Dec 31, 2025Net Income
-7.86BKRWFY2025 · Dec 31, 2025EBIT
-7.61BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
-6.35BKRWFY2025 · Dec 31, 2025Research & Development
4.48BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
1.99BKRWFY2025 · Dec 31, 2025Other Operating Expenses
724.28MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
147.92MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
255.21MKRWFY2025 · Dec 31, 2025EPS (Basic)
-1.20KKRWFY2025 · Dec 31, 2025EPS (Diluted)
-1.20KKRWFY2025 · Dec 31, 2025Basic Shares Outstanding
6.54MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
6.54MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-7.86BKRWFY2025 · Dec 31, 2025Operating Cash Flow
-9.59BKRWFY2025 · Dec 31, 2025Free Cash Flow
-11.82BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
23.76BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-7.86BKRWFY2025 · Dec 31, 2025Stock-based Compensation
62.60MKRWFY2025 · Dec 31, 2025Other Non-cash Items
58.79MKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.11BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-738.94MKRWFY2025 · Dec 31, 2025Capital Expenditures
-2.23BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-71.62MKRWFY2025 · Dec 31, 2025Purchase of Investments
-44.44MKRWFY2025 · Dec 31, 2025Sale of Investments
81.48MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.19BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-1.02BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-422.61MKRWFY2025 · Dec 31, 2025Other Financing Charges
2.80MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
24.43BKRWFY2025 · Dec 31, 2025Shares Outstanding
7.62MSharesUpdated Jul 15, 2026Float Shares
5.33MSharesUpdated Jul 15, 2026% Held by Insiders
28.72%vs all stocks
% Held by Institutions
7.08%vs all stocks
Total Cash (MRQ)
22.10BKRW15.51M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.90KKRWUpdated Jul 15, 2026Total Debt (MRQ)
3.14BKRW2.21M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1177xvs Medical Devices peers
Current Ratio (MRQ)
8.13xvs Medical Devices peers
Book Value per Share (MRQ)
3.51KKRWUpdated Jul 15, 2026Total Assets
34.23BKRW24.02M · vs all stocks (USD)
Total Current Assets
28.54BKRWFY2025 · Dec 31, 2025Total Liabilities
6.03BKRWFY2025 · Dec 31, 2025Total Non-current Assets
5.69BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
2.79BKRWFY2025 · Dec 31, 2025Total Current Liabilities
3.24BKRWFY2025 · Dec 31, 2025Cash Equivalents
23.76BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
23.76BKRWFY2025 · Dec 31, 2025Other Short-term Investments
437.99MKRWFY2025 · Dec 31, 2025Accounts Receivable
993.99MKRWFY2025 · Dec 31, 2025Inventory
2.60BKRWFY2025 · Dec 31, 2025Accounts Payable
58.73MKRWFY2025 · Dec 31, 2025Short-term Debt
2.48BKRWFY2025 · Dec 31, 2025Other Current Liabilities
-890.00KRWFY2025 · Dec 31, 2025Long-term Debt
724.64MKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-780.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
3.81BKRWFY2025 · Dec 31, 2025Retained Earnings
-42.89BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
28.20BKRW19.79M · vs all stocks (USD)
52-Week Low
11.61KKRWUpdated Jul 15, 202652-Week High
96.40KKRWUpdated Jul 15, 202652-Week Change
-29.91%vs all stocks
50-Day MA
35.20KKRWUpdated Jul 15, 2026200-Day MA
54.49KKRWUpdated Jul 15, 2026Avg 10-Day Volume
96.66KSharesUpdated Jul 15, 2026Avg 30-Day Volume
101.21KSharesUpdated Jul 15, 2026Diluted EPS (TTM)
-1.20KKRWUpdated Jul 15, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -140.2%, lower than 95% of its Medical Devices peers (median 8.1%)Significant
Operating margin: -1.40Industry median: 0.08Industry P5: -0.73Peers compared: 102
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 27.63Revenue Growth YoY: -0.22
Financial Health
Altman Z-Score 10.3: safe zoneNotable
Altman Z-Score: 10.30
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $82.41M, lower than 95% of all stocks globallySignificant
Market cap (USD): 82,407,267.321Global P5: 269,387,740.27
Revenue is $4.9M, lower than 95% of all stocks globallySignificant
Revenue (USD): 4,902,986.506Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Poolbeg Pharma plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Eco Animal Health Group PLC
Tier 1ProductionApproval-Gated PipelineRule
Creo Medical Group plc
Tier 1ProductionApproval-Gated PipelineRule
Bonus BioGroup Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kala Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Y-Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Faron Pharmaceuticals Oy
Tier 1ProductionApproval-Gated PipelineRuleRisk
Engene Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRule
Polaryx Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nibec Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Halo Microelectronics Co., Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityCash Elevated Relative to Current Liabilities and Total Assets
Hebei Sinopack Electronic Co., Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityCash Elevated Relative to Current Liabilities and Total Assets
Telos Corporation
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityCash Elevated Relative to Current Liabilities and Total Assets